Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lithium cocrystal - Alzamend Neuro

Next Previous
X
Search
Drug Profile

Lithium cocrystal - Alzamend Neuro

Alternative Names: AL-001-Alzamend Neuro; LiProSal; LiProSalTM

Latest Information Update: 29 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of South Florida
  • Developer Alzamend Neuro
  • Class Alkali metals; Antidementias; Antidepressants; Antimanics; Antipsychotics; Light metals; Small molecules
  • Mechanism of Action Neuron modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Alzheimer's disease
  • Preclinical Bipolar disorders; Major depressive disorder; Post-traumatic stress disorders

Most Recent Events

  • 26 Aug 2024 Alzamed Neuro plans the phase IIa AL001-PTSD01 trial for Post traumatic stress disorder in USA in 1H of 2025 (Alzamend Neuro pipeline, August 2024)
  • 26 Aug 2024 Alzamend Neuro plans a phase II trial for Bipolar disorders in 1H of 2025
  • 26 Aug 2024 Alzamend Neuro plans a two phase IIa clinical trials for Alzheimer’s disease by 1H of 2025

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top